Mammographic breast cancer screening for women previously treated with high breast doses for diseases such as Hodgkin's
Mammographic breast cancer screening for women previously treated with high breast doses for diseases such as Hodgkin's
复制标题
DOI：
10.1093/rpd/nci766
复制
发表时间：
2005-01-01
影响因子：
1
通讯作者：
Law, J
中科院分区：
文献类型：
--
作者：
Faulkner, K;Law, J
在一般人群的乳腺癌筛查中，获益/风险比约为100/1。对于年龄低于35岁的霍奇金病放疗治疗的妇女的非常小的亚组，这种类型的计算需要不同的考虑，在本文中给出了概述。得出的结论是，虽然这种以前的暴露会增加他们的辐射风险，他们携带未被发现的乳腺癌的风险增加意味着他们的筛查的潜在好处是增加更多。在英国，卫生部建议每年对这些妇女进行筛查。
In screening of a general population for breast cancer, benefit/risk ratios are of the order of 100/1. For the very small subgroup of women treated by radiotherapy for Hodgkin's disease below age 35, calculations of this type require different considerations, an overview of which is given in this text. It is concluded that although such previous exposures will increase their radiation risk, their increased risk of carrying an undetected breast cancer means that the potential benefit for them of screening is increased even more. In the United Kingdom, the Department of Health has recommended annual screening for these women.